As a researcher and as a thoracic surgeon, John Wain, MD, is on a ceaseless quest to raise the standard of care for patients with cancer.
Dr. Wain is the head of Thoracic Surgical Research and surgical director of the Lung Transplant Program at the Mass General Cancer Center, where he initiated living donor lung transplantation in New England. He has a long term research interest in both epigenetic risk factors and the molecular epidemiology of lung cancer. Currently, Dr. Wain is conducting research in tracheal epithelial regeneration and its relationship to cancer formation.
Dr. Wain’s vigilance on behalf of patients encompasses process improvements as well as meticulous attention to their care. For example, he has pioneered the use of thoracoscopic lung resection and has helped to develop protocols to reduce complications after thoracic surgery.
“Dr. Wain is an extremely kind, humble man with outstanding talent as a surgeon and a deep commitment to making the experience of treatment a positive one for each patient,” writes Deidre Malloy. “My sister is a survivor of stage I lung cancer and I am an eight-year survivor of stage IIIb lung cancer. We owe our lives to Dr. Wain. And many other patients feel the same way.”
